Smallcap momentum portfolio

Update for entry on 11th November 2024 (lookback dates: 10/11/2023 and 10/05/2024)

50EMA (17,847) > 200EMA (16,445); hence, we can continue without any change.

Based on ranking:

1. GET&D
2. SUVENPHAR
3. MOTILALOFS
4. JUBLPHARMA
5. ANANTRAJ
6. DEEPAKFERT
7. GLENMARK
8. NETWEB
9. BASF
10. PPLPHARMA
11. GODFRYPHLP
12. MCX
13. FSL
14. POLYMED
15. INOXWIND
16. KAYNES
17. HSCL
18. DOMS
19. NATCOPHARM
20. ERIS

Based on A → Z for easy tracking:

• ANANTRAJ
• BASF
• DEEPAKFERT
• DOMS
• ERIS
• FSL*
• GET&D
• GLENMARK
• GODFRYPHLP
• HSCL
• INOXWIND
• JUBLPHARMA
• KAYNES
• MCX
• MOTILALOFS
• NATCOPHARM*
• NETWEB
• POLYMED
• PPLPHARMA
• SUVENPHAR

Exits:
BIKAJI and TECHNOE stay within the top 25 and hence remain.

Entries:
FSL and NATCOPHARM cannot enter as there is no vacancy.

Note: The above information is provided for educational purposes only. Please consult your Financial advisor before any investment.